Vasanthavada Madhav Insider Trades

Insider Trading History

Track insider trading activity for Vasanthavada Madhav. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Abeona Therapeutics
Abeona Therapeutics ABEO
Chief Commercial Officer
Holding Value $2.21M 303,229 shares
Last Trade
Jun 16, 2026 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$1.26k 222 shares
$5.67
$7.29
Abeona Therapeutics
Abeona Therapeutics ABEO
Chief Commercial Officer
Holding Value $2.21M 303,451 shares
Last Trade
Jun 09, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$28.9k 5,450 shares
$5.30
$7.29
Abeona Therapeutics
Abeona Therapeutics ABEO
Chief Commercial Officer
Holding Value $2.25M 308,901 shares
Last Trade
Jun 08, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$22.6k 4,170 shares
$5.43
$7.29
Abeona Therapeutics
Abeona Therapeutics ABEO
Chief Commercial Officer
Holding Value $2.28M 313,071 shares
Last Trade
May 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$33.1k 5,548 shares
$5.96
$7.29
Abeona Therapeutics
Abeona Therapeutics ABEO
Chief Commercial Officer
Holding Value $2.32M 318,619 shares
Last Trade
Jan 22, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$66.7k 12,610 shares
$5.29
$7.29
Abeona Therapeutics
Abeona Therapeutics ABEO
Chief Commercial Officer
Holding Value $2.41M 331,229 shares
Last Trade
Jan 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$406k 76,621 shares
$5.30
$7.29
Abeona Therapeutics
Abeona Therapeutics ABEO
Chief Commercial Officer
Holding Value $1.86M 254,608 shares
Last Trade
Jan 01, 2026 Sale
$12.7k 2,400 shares
$5.30
$7.29

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up